4.82
前日終値:
$4.87
開ける:
$4.91
24時間の取引高:
14,612
Relative Volume:
0.08
時価総額:
$4.00M
収益:
$275.60K
当期純損益:
$-8.33M
株価収益率:
-10.44
EPS:
-0.4619
ネットキャッシュフロー:
$-5.40M
1週間 パフォーマンス:
-4.74%
1か月 パフォーマンス:
+1,246%
6か月 パフォーマンス:
+1,028%
1年 パフォーマンス:
+455.62%
Nexalin Technology Inc Stock (NXL) Company Profile
Compare NXL vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
NXL
Nexalin Technology Inc
|
4.82 | 4.04M | 275.60K | -8.33M | -5.40M | -0.4619 |
|
ABT
Abbott Laboratories
|
101.95 | 178.85B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
90.96 | 117.19B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
275.56 | 103.57B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
42.98 | 62.46B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
84.37 | 50.01B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nexalin Technology Inc (NXL) 最新ニュース
Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - ACCESS Newswire
Nexalin Technology Announces Key Executive Leadership Departure - TipRanks
NXL Should I Buy - Intellectia AI
Nexalin Technology registers to sell 5.75M shares of common stock for holders - TipRanks
Multi-million-share resale could boost Nexalin (NASDAQ: NXL) share count - Stock Titan
Greenlight Ventures Discloses Investment at Nexalin Technology with 5.6% Stake - TradingView
Stock-for-deal investor steps in at Nexalin (NASDAQ: NXL) - Stock Titan
Nexalin Technology (NASDAQ: NXL) Announces Carolyn Shelton's Exit with $20,000 Bonus and Accelerated Stock Option Vesting - Kalkine Media
Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to - Yahoo Finance
Carolyn Shelton exits Nexalin as Senior VP; separation terms include bonus and option vesting - TradingView
Nexalin Technology, Inc. Announces Resignation of Carolyn Shelton from Senior Vice President of Quality, Regulatory, and Clinical Affairs, Effective August 28, 2026 - marketscreener.com
Alumni Capital LP Holds 9.99% Stake in Nexalin Technology (NASDAQ: NXL), Disclosing 2.49 Million Shares - Kalkine Media
Nexalin Technology Inc. (NASDAQ: NXL) Share Price, NXL Stock News, NXL Share Price & Updates - Kalkine
Nexalin Technology approves 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria
Nexalin Technology Announces 1-for-30 Reverse Stock Split to Maintain Nasdaq Compliance - Quiver Quantitative
Nexalin Technology approves 1-for-30 reverse stock split - Investing.com
Nexalin Technology Raises Liquidity via Short-Term Note - TipRanks
Nexalin Technology Issues $1.17 Million OID Note for $1.0 Million Proceeds - TradingView
Nexalin Announces Capital Raise and Flexible Equity Facility - TipRanks
Nexalin Technology Raises $750,000 in Registered Direct Offering - Minichart
Nexalin Technology Announces $0.75M Direct Offering and $15M Equity Purchase Facility With Alumni Capital - TradingView
Nexalin (NXL) EPS and Revenue: EPS Does Not Reach the Reported Estimate in the Available Record; The Share Price Sheds 2.06% in Latest TradingEPS Guidance Update - dars.gov.et
Nexalin Faces New Nasdaq Equity Deficiency, Delisting Risk - The Globe and Mail
Nexalin Technology Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nexalin Technology earnings missed, revenue fell short of estimates By Investing.com - Investing.com South Africa
Nexalin Technology earnings missed, revenue fell short of estimates - Investing.com
Nexalin Technology (NXL) Edges Higher at $0.36 as Neurostimulation Stock Holds Key SupportIceberg Order - dars.gov.et
Nexalin Technology, Inc. 2Q 2026: Revenue $12.16K, EPS ($0.11) — 10-Q Summary - TradingView
Nexalin Technology (NXL) flags going concern risk as losses mount and Nasdaq warns - Stock Titan
Nexalin Technology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nexalin Technology | 8-K: Current report - Moomoo
Nexalin Technology Inc (NXL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nexalin Technology Inc (NXL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nexalin Technology Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Nexalin Expands and Extends Houston Headquarters Lease Commitment - The Globe and Mail
Nexalin Technology Inc (NXL) Institutional Confidence - TradingKey
Nexalin Appeals Nasdaq Delisting Following Compliance Shortfalls - TipRanks
Nexalin Technology Received Notice of Delisting - TradingView
Nexalin Technology Inc (NXL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NXL|Nexalin Technology Inc|Price:0.353|Chg%:+0.014 - TradingKey
Nexalin Technology Inc (NXL) Cash Flow - TradingKey
Nexalin Technology Inc (NXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NXL|Nexalin Technology Inc|Price:0.500|Chg%:+0.019 - TradingKey
Nexalin Technology Inc (NXL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nexalin Technology Inc (NXL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
NXL|Nexalin Technology Inc|Price:0.481|Chg%:+0.013 - TradingKey
NXL Q1 2026 Earnings: EPS Misses Estimates as Company Advances Non-Invasive Neuromodulation PipelineNew Analyst Coverage - vinanet.vn
Nexalin Technology, Inc. Revenue Breakdown – NASDAQ:NXL - TradingView
NXL Q1 2026 Earnings: EPS Misses Estimates by 8.91% While Shares Edge HigherQuarterly Profit Report - vinanet.vn
NXL Q1 2026 Earnings: Loss Per Share Misses Estimates as Development Continues Without Revenue - vinanet.vn
Nexalin Technology (NXL) Registration filing Summary - Quartr
Nexalin Technology Inc (NXL) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):